"This is not only cost effective, this is massively cost effective, perhaps the most cost-effective thing we’ve ever done in our field," he said.
Dr. Scott has been an adviser to EMD Serono and Ferring Pharmaceuticals.
On Twitter @sherryboschert
*Correction, 9/11/2013: An earlier version of this story attributed the 31% clinical miscarriage rate per single gestational sac to the wrong treatment group.